Literature DB >> 2540240

A rapid method for quantitation of antiviral antibodies.

J D Peterson1, J Y Kim, R W Melvold, S D Miller, C Waltenbaugh.   

Abstract

This paper examines the parameters necessary for the efficient measurement of anti-Theiler's murine encephalomyelitis virus (TMEV) antibodies in an affinity-dependent manner using a variation of a solid-phase particle concentration fluorescence immunoassay (PCFIA). By allowing antibody to react with fluorochrome-labelled virus in fluid phase and subsequently capturing the resulting virus-antibody complexes with anti-immunoglobulin coated polystyrene particles (fluid-phase PCFIA), the present assay allows for both greater sensitivity, specificity and preservation of conformational viral epitopes than do solid-phase immunoassays. Fluid-phase PCFIA proved to be a more rapid quantitative assay than ELISA and significantly diminished non-specific binding by both untreated and heat-inactivated normal mouse sera. This methodology also allowed us to perform competition assays and to determine the dissociation kinetics of anti-viral antibody preparations, investigations which cannot generally be performed as solid-phase immunoassays. Thus fluid-phase PCFIA is a rapid and efficient immunoassay with excellent reproducibility and great versatility.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540240     DOI: 10.1016/0022-1759(89)90384-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  Fluorescence immunoassay for detecting periodontal bacterial pathogens in plaque.

Authors:  L F Wolff; L Anderson; G P Sandberg; D M Aeppli; C E Shelburne
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

2.  Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination.

Authors:  S D Miller; S J Gerety; M K Kennedy; J D Peterson; J L Trotter; V K Tuohy; C Waltenbaugh; M C Dal Canto; H L Lipton
Journal:  J Neuroimmunol       Date:  1990-01       Impact factor: 3.478

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.